Product NDC: | 40032-030 |
Proprietary Name: | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
Non Proprietary Name: | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
Active Ingredient(s): | .398; 1.105 g/1; g/1 & nbsp; Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 40032-030 |
Labeler Name: | Novel Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079247 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120120 |
Package NDC: | 40032-030-01 |
Package Description: | 100 TABLET in 1 BOTTLE (40032-030-01) |
NDC Code | 40032-030-01 |
Proprietary Name | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
Package Description | 100 TABLET in 1 BOTTLE (40032-030-01) |
Product NDC | 40032-030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120120 |
Marketing Category Name | ANDA |
Labeler Name | Novel Laboratories, Inc. |
Substance Name | SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Strength Number | .398; 1.105 |
Strength Unit | g/1; g/1 |
Pharmaceutical Classes |